login
  Password reminder
Cardiac Rhythm News
Contact the editor Visit Cardiac Rhythm News Twitter feed Visit Cardiac Rhythm News Facebook page
 

Stereotaxis initiates shipments of the Epoch electrophysiology platform


Friday, 16 Dec 2011 10:32

Stereotaxis has started shipments of the Epoch platform, its comprehensive solution for the electrophysiology (EP) lab that is designed to increase efficiency in procedures with a fully-remote, networked robotic and magnetic navigation system. 


Initial shipments include system upgrades to the new generation Epoch platform from the Niobe II navigation system for customers in the USA and Europe. The company also announced the installation of the Vdrive Duo mechanical arm robotic navigation system, as part of the Epoch upgrades in Europe. The Vdrive Duo arm allows physicians to remotely manipulate a growing array of devices, such as the loop diagnostic catheter and sheath, while also manipulating the magnetic catheter.


The Epoch platform is designed to improve efficiency and enhance workflow by allowing the physician to control all aspects of the procedure remotely. It combines the proven value of remote magnetic catheter control and the efficiency benefits of remote robotic device manipulation with the Vdrive mechanical arm.


“The Epoch platform has generated tremendous market excitement since its introduction at the annual Heart Rhythm Society meeting in May,” said Michael P Kaminski, president and CEO of Stereotaxis. “As expected, the initial wave of commitments is coming from current customers who see the clear benefit to upgrade their system to Epoch. Additionally, we have experienced a surge in new prospective customers visiting our headquarters to understand how Epoch would fit their EP lab needs. We are excited about the interest in Epoch from current users and the demand curve for prospective customers, and believe we are poised for strong performance in 2012.”




Add New Comment

Related Items


Most popular


Friday, 18 Jul 2014
Even in moderation, consumption of wine and hard liquor may be a risk factor for atrial fibrillation, according to new research recently published in the Journal of the American College of Cardiology.... Moderate alcohol use associated with increased risk for atrial fibrillation

First European experience with ProTrack at St George’s Hospital London
Wednesday, 02 Jul 2014
The first cases using the ProTrack Pigtail wire in Europe were performed last month at St George’s Hospital in London, UK. The ProTrack Pigtail wire is used during the transseptal procedure, a ... First European experience with ProTrack at St George’s Hospital London

Physicians implant world's first ProMRI Quadripolar CRT-D system to treat heart failure
Tuesday, 15 Jul 2014
With Sentus quadripolar leads and the Inventra series, Biotronik offers the only devices for patients with heart failure worldwide that are approved for MRI use. Physicians implant world's first ProMRI Quadripolar CRT-D system to treat heart failure

Features


Sports for young patients with implantable cardioverter defibrillators: Refining the risk
Wednesday, 13 Aug 2014
Elizabeth Saarel (University of Utah, Salt Lake City, USA) argues that, based on prospective registry data, young patients with implantable cardioverter defibrillators can participate safely in ... Sports for young patients with implantable cardioverter defibrillators: Refining the risk

Is antiarrhythmic gene therapy the future of atrial fibrillation management?
Thursday, 31 Jul 2014
Dierk Thomas (Heidelberg, Germany) writes on the results of preclinical research on antiarrhythmic gene therapy. Is antiarrhythmic gene therapy the future of atrial fibrillation management?

Profiles


Nick Linker
Monday, 14 Jul 2014
Nick Linker is president-elect of the British Heart Rhythm Society (BHRS) and programme director of ... Nick Linker

Richard Fogel
Thursday, 08 May 2014
Richard Fogel, president-elect of the Heart Rhythm Society and chief executive officer at St V... Richard Fogel

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions